Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

responsive web design (RWD)

- PMLiVE

Keytruda combo outshines Opdivo in kidney cancer

BMS also on the backfoot after Nektar data release

- PMLiVE

Bicycle Therapeutics to tackle AMR with government funding

Biotech to discover new class of antibacterial agents

- PMLiVE

FDA panel backs J&J’s new-class antidepressant

Set to be first novel antidepressant approved since Prozac in 1987

- PMLiVE

Medicinal cannabis firm Althea enters UK market

It will start supplying products next month

- PMLiVE

New faces at BioStrata, PSL Group and FCB Health

The latest movers in healthcare comms

Putting disease prevention on a par with cure

Steve How and Paul Midgley, of the Wilmington Healthcare Consulting Team, explore how the NHS is taking an increasingly holistic approach to care

Wilmington Healthcare

Putting our mission into practice: Porterhouse Medical’s charity round-up 2018 – 2019

As part of our mission to help improve people’s lives, each year Porterhouse Medical selects a local charity partner to support with fundraising events, using our communications expertise to raise...

Porterhouse Medical Group

- PMLiVE

AbbVie enters BCMA race with Teneobio deal

Agreement includes option to acquire TeneoOne

- PMLiVE

Industry aghast as EU Parliament backs biosimilar rule change

The change could come into effect in 2021

Pharma iPad detailing doctors physicians

A genomics and digital-led NHS is possible – but investment in staff essential

Powerful technologies will lead to an “evolution of the patient-doctor relationship”

- PMLiVE

Gilead lead NASH drug flunks phase 3 test

Analysts suspect the setback could prompt Gilead to license other candidates

- PMLiVE

Industry concerned about ‘rushed’ Brexit withdrawal legislation

The Patents Amendment could weaken the UK’s IP framework, warns biopharma

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links